(` cr) Note 21 Contract liabilities As at March 31, 2025 As at March 31, 2024 Discount payables 15.97 19.72 Advances received from customers 17.19 18.12 33.16 37.84 (` cr) Note 22 Revenue from operations 2024-25 2023-24 Sale of products 5,361.81 4,601.96 Sale of services1 148.13 66.06 Scrap sales 13.11 14.94 Commission received 0.07 - Revenue from contracts with customers 5,523.12 4,682.96 Export incentives 60.23 42.72 5,583.35 4,725.68 1Includes ` 141.80 cr (2023-24: ` 61.01 cr) on account of freight and insurance in sale of goods on CIF, which are identified as separate performance obligation under Ind AS 115. Disaggregation of revenue from contracts with customers (` cr) Particulars 2024-25 2023-24 Sale of goods | services Life Science Chemicals 1,673.12 1,478.77 Domestic 907.08 776.48 Export 766.04 702.29 Performance and Other Chemicals 4,016.17 3,358.35 Domestic 2,332.80 1,982.88 Export 1,683.37 1,375.47 Others 74.30 62.90 5,763.59 4,900.02 Inter-segment revenue 240.47 217.06 5,523.12 4,682.96 Reconciliation of revenue from contracts with customers recognised at contract price (` cr) Particulars 2024-25 2023-24 Contract price 5,647.71 4,773.06 Adjustments for: Consideration payable to customers - discounts1 (127.55) (84.23) Contract price allocated to unsatisfied performance obligation for sale of services (net)2 2.96 (5.87) Revenue from contracts with customers 5,523.12 4,682.96 1Consideration payable to customers like discounts and price reductions offered to customers are estimated on specific identified basis and reduced from the contract price when the Group recognises revenue from the transfer of the related goods or services to the customer and the entity pays or promises to pay the consideration. 2Unsatisfied performance obligation for sale of services comprises revenue from insurance and freight services for exports in-progress as at March 31, 2025, of ` 10.45 cr, net of revenue recognised for such services for similar contracts in-progress as at March 31, 2024, for ` 13.41 cr. The revenue for exports in-progress as at March 31, 2025, will be recognised in 2025-26 upon completion of the exports. 268 268 Integrated Annual Report 2024-25
RkJQdWJsaXNoZXIy MjA2MDI2